Annual EBIT:
-$120.82M+$67.60M(+35.88%)Summary
- As of today, NVCR annual earnings before interest & taxes is -$120.82 million, with the most recent change of +$67.60 million (+35.88%) on December 31, 2024.
- During the last 3 years, NVCR annual EBIT has fallen by -$72.18 million (-148.42%).
- NVCR annual EBIT is now -438.58% below its all-time high of $35.68 million, reached on December 31, 2020.
Performance
NVCR EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
$0.00+$39.52M(+100.00%)Summary
- As of today, NVCR quarterly earnings before interest & taxes is $0.00, with the most recent change of +$39.52 million (+100.00%) on September 30, 2025.
- Over the past year, NVCR quarterly EBIT has increased by +$32.09 million (+100.00%).
- NVCR quarterly EBIT is now -100.00% below its all-time high of $15.02 million, reached on September 30, 2020.
Performance
NVCR Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$139.74M+$32.09M(+18.68%)Summary
- As of today, NVCR TTM earnings before interest & taxes is -$139.74 million, with the most recent change of +$32.09 million (+18.68%) on September 30, 2025.
- Over the past year, NVCR TTM EBIT has increased by +$10.45 million (+6.96%).
- NVCR TTM EBIT is now -514.72% below its all-time high of $33.69 million, reached on March 31, 2021.
Performance
NVCR TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
NVCR EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +35.9% | +100.0% | +7.0% |
| 3Y3 Years | -148.4% | +100.0% | -99.8% |
| 5Y5 Years | -2492.5% | -100.0% | -856.9% |
NVCR EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -148.4% | +35.9% | at high | +100.0% | -99.8% | +38.2% |
| 5Y | 5-Year | -438.6% | +35.9% | -100.0% | +100.0% | -514.7% | +38.2% |
| All-Time | All-Time | -438.6% | +35.9% | -100.0% | +100.0% | -514.7% | +38.2% |
NVCR EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $0.00(+100.0%) | -$139.74M(+18.7%) |
| Jun 2025 | - | -$39.52M(-4.4%) | -$171.83M(-3.6%) |
| Mar 2025 | - | -$37.87M(+39.3%) | -$165.91M(+1.0%) |
| Dec 2024 | -$120.82M(+35.9%) | -$62.35M(-94.3%) | -$167.54M(-11.6%) |
| Sep 2024 | - | -$32.09M(+4.5%) | -$150.19M(+14.8%) |
| Jun 2024 | - | -$33.61M(+14.9%) | -$176.34M(+14.1%) |
| Mar 2024 | - | -$39.49M(+12.3%) | -$205.40M(+9.2%) |
| Dec 2023 | -$188.42M(-140.0%) | -$45.00M(+22.7%) | -$226.16M(-0.9%) |
| Sep 2023 | - | -$58.24M(+7.0%) | -$224.13M(-17.7%) |
| Jun 2023 | - | -$62.66M(-4.0%) | -$190.50M(-27.9%) |
| Mar 2023 | - | -$60.25M(-40.2%) | -$148.97M(-66.4%) |
| Dec 2022 | -$78.51M(-61.4%) | -$42.98M(-74.6%) | -$89.52M(-28.0%) |
| Sep 2022 | - | -$24.61M(-16.5%) | -$69.94M(-29.8%) |
| Jun 2022 | - | -$21.13M(-2521.3%) | -$53.88M(-19.6%) |
| Mar 2022 | - | -$806.00K(+96.6%) | -$45.05M(-1.6%) |
| Dec 2021 | -$48.63M(-236.3%) | -$23.40M(-173.6%) | -$44.33M(-401.3%) |
| Sep 2021 | - | -$8.55M(+30.4%) | -$8.84M(-160.0%) |
| Jun 2021 | - | -$12.29M(>-9900.0%) | $14.73M(-56.3%) |
| Mar 2021 | - | -$88.00K(-100.7%) | $33.69M(+10.8%) |
| Dec 2020 | $35.68M(+606.6%) | $12.09M(-19.5%) | $30.40M(+64.7%) |
| Sep 2020 | - | $15.02M(+125.3%) | $18.46M(+153.1%) |
| Jun 2020 | - | $6.67M(+297.2%) | $7.29M(+300.3%) |
| Mar 2020 | - | -$3.38M(-2324.3%) | $1.82M(+299.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $5.05M(+117.0%) | $152.00K(-96.1%) | -$915.00K(+90.6%) |
| Sep 2019 | - | $3.85M(+222.3%) | -$9.73M(+48.3%) |
| Jun 2019 | - | $1.20M(+119.5%) | -$18.83M(+30.5%) |
| Mar 2019 | - | -$6.12M(+29.4%) | -$27.11M(+19.5%) |
| Dec 2018 | -$29.67M(+22.4%) | -$8.66M(-65.2%) | -$33.67M(-14.1%) |
| Sep 2018 | - | -$5.25M(+26.0%) | -$29.51M(+2.2%) |
| Jun 2018 | - | -$7.08M(+44.1%) | -$30.19M(+21.9%) |
| Mar 2018 | - | -$12.68M(-181.3%) | -$38.63M(+1.8%) |
| Dec 2017 | -$38.24M(+66.9%) | -$4.51M(+23.9%) | -$39.33M(+25.4%) |
| Sep 2017 | - | -$5.92M(+61.9%) | -$52.70M(+29.8%) |
| Jun 2017 | - | -$15.53M(-16.1%) | -$75.05M(+16.9%) |
| Mar 2017 | - | -$13.37M(+25.2%) | -$90.34M(+17.0%) |
| Dec 2016 | -$115.53M(-10.3%) | -$17.88M(+36.8%) | -$108.91M(+10.5%) |
| Sep 2016 | - | -$28.27M(+8.3%) | -$121.63M(-3.4%) |
| Jun 2016 | - | -$30.82M(+3.5%) | -$117.60M(-3.2%) |
| Mar 2016 | - | -$31.94M(-4.4%) | -$113.98M(-9.6%) |
| Dec 2015 | -$104.77M(-30.5%) | -$30.60M(-26.3%) | -$103.96M(-41.7%) |
| Sep 2015 | - | -$24.24M(+10.9%) | -$73.36M(-49.3%) |
| Jun 2015 | - | -$27.20M(-24.1%) | -$49.12M(-13.8%) |
| Mar 2015 | - | -$21.91M(-3.2%) | -$43.15M(-10.0%) |
| Dec 2014 | -$80.26M(-14.9%) | - | - |
| Jun 2014 | - | -$21.23M(-17.9%) | -$39.24M(-117.9%) |
| Mar 2014 | - | -$18.01M | -$18.01M |
| Dec 2013 | -$69.86M | - | - |
FAQ
- What is NovoCure Limited annual earnings before interest & taxes?
- What is the all-time high annual EBIT for NovoCure Limited?
- What is NovoCure Limited annual EBIT year-on-year change?
- What is NovoCure Limited quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for NovoCure Limited?
- What is NovoCure Limited quarterly EBIT year-on-year change?
- What is NovoCure Limited TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for NovoCure Limited?
- What is NovoCure Limited TTM EBIT year-on-year change?
What is NovoCure Limited annual earnings before interest & taxes?
The current annual EBIT of NVCR is -$120.82M
What is the all-time high annual EBIT for NovoCure Limited?
NovoCure Limited all-time high annual earnings before interest & taxes is $35.68M
What is NovoCure Limited annual EBIT year-on-year change?
Over the past year, NVCR annual earnings before interest & taxes has changed by +$67.60M (+35.88%)
What is NovoCure Limited quarterly earnings before interest & taxes?
The current quarterly EBIT of NVCR is $0.00
What is the all-time high quarterly EBIT for NovoCure Limited?
NovoCure Limited all-time high quarterly earnings before interest & taxes is $15.02M
What is NovoCure Limited quarterly EBIT year-on-year change?
Over the past year, NVCR quarterly earnings before interest & taxes has changed by +$32.09M (+100.00%)
What is NovoCure Limited TTM earnings before interest & taxes?
The current TTM EBIT of NVCR is -$139.74M
What is the all-time high TTM EBIT for NovoCure Limited?
NovoCure Limited all-time high TTM earnings before interest & taxes is $33.69M
What is NovoCure Limited TTM EBIT year-on-year change?
Over the past year, NVCR TTM earnings before interest & taxes has changed by +$10.45M (+6.96%)